Correction to: Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study

Authors

Tobias Siegfried Kramer
Alex Soriano
Sarah Tedeschi
Antonia Chen
Pierre Tattevin
Eric Senneville
Joan Gomez-Junyent
Victoria Birlutiu
Sabine Petersdorf
Vicens Diaz de Brito
Ignacio Sancho Gonzalez
Katherine Belden, Thomas Jefferson UniversityFollow
Marjan Wouthuyzen-Bakker

Document Type

Letter to the Editor

Publication Date

2-8-2024

Comments

This article is the author's final published version in Open Forum Infectious Diseases, Volume 11, Issue 3, 2024, Article number ofae075.

The published version is available at https://doi.org/10.1093/ofid/ofae075.

Copyright © The Author(s) 2024.

See original article: https://jdc.jefferson.edu/didem/16/.

Recommended Citation

Kramer, Tobias Siegfried; Soriano, Alex; Tedeschi, Sarah; Chen, Antonia; Tattevin, Pierre; Senneville, Eric; Gomez-Junyent, Joan; Birlutiu, Victoria; Petersdorf, Sabine; de Brito, Vicens Diaz; Gonzalez, Ignacio Sancho; Belden, Katherine; and Wouthuyzen-Bakker, Marjan, "Correction to: Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study" (2024). Division of Infectious Diseases and Environmental Medicine Faculty Papers. Paper 17.
https://jdc.jefferson.edu/didem/17

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Language

English